Jean‐François Laprise

Global policy determinants of national human papillomavirus vaccine introductions in 2006–2025

BACKGROUND: Although safe and effective human papillomavirus (HPV) vaccines have been available since 2006, national introduction in low- and middle-income countries (LMICs) has progressed slowly. HPV vaccine adoption may have been shaped by evolving World Health Organization (WH...